Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

LEAMINGTON, Ontario, June 29, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis division, Tilray Medical, has expanded its medical cannabis offerings in the United Kingdom. Tilray Medical now offers the broadest portfolio of cannabis flower in the UK market today, including a differentiated range of high THC products, cultivated at its EU-GMP-certified facility in Portugal.

Tilray Medical Expands Portfolio of Medical Cannabis Products in the UK

Aurora Cannabis

Canopy Growth

Will These Marijuana Stocks Uplist If The CLIMB Act Becomes Law The post The CLIMB Act May Help Marijuana Stocks Trade Better appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

The CLIMB Act May Help Marijuana Stocks Trade Better

Cantor Fitzgerald's upgrade of ACB stock today appears to be lifting the shares.. The firm is upbeat on the company's opportunity in Germany.

Cannabis Stocks ACB, TLRY Heat Up on European Expansion Hopes

Tilray faces some serious challenges. However, at $3 per share, people have already priced in a close-to-worst case scenario for TLRY stock.

It Can't Get Much Worse Than This for Tilray Stock

Coupang

Lithium Americas Corp

Li Auto Inc.

Rada Electronic

These growth stocks may look cheap now, but give it 5 years and they'll be some of the biggest names in their sectors. The post 5 Growth Stocks to Buy for 5-Bagger Returns in 5 Years appeared first on InvestorPlace.

5 Growth Stocks to Buy for 5-Bagger Returns in 5 Years

Arrival Group

Hecla Mining

Kinross Gold

Mullen Automotive

Transocean

Riot Blockchain

Penny stocks that look attractive after correction and can be considered for the long-term for multi-fold returns. The post 7 Penny Stocks to Buy After the Market Crash appeared first on InvestorPlace.

7 Penny Stocks to Buy After the Market Crash

Tesla

Investors should be careful with these two stocks.

2 Crashing Nasdaq Stocks That You Shouldn't Buy on the Dip

AFC Gamma

Amplify Seymour Cannabis ETF

Cronos Group

Curaleaf Holdings, Inc.

GrowGeneration Corp

Hydrofarm Holdings Group

Innovative Industrial Properties

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

NewLake Capital Partners, Inc.

Global X Cannabis ETF

Power REIT

Chicago Atlantic Real Estate Finance

Scotts Miracle-Gro

Trulieve Cannabis Corp.

Cambria Cannabis ETF

Village Farms International

AdvisorShares Pure Cannabis ETF 

Cannabis REITs - a perennial performance leader over the past half-decade - have been slammed in 2022 amid concerns over tenant financial health given the sharp re-pricing of risk and tighter financial conditions. Owning the "Pharmland" - the physical real estate - had been one of the few cannabis plays that was working amid a decade-long stretch of dismal investment performance from broader cannabis ETFs.

Cannabis REITs: Weeding Out The Weak

OrganiGram Holdings Inc.

SNDL Inc.

Top Canadian Marijuana Stocks To Watch This Month The post 3 Canadian Marijuana Stocks For Your June 2022 Watch List appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Canadian Marijuana Stocks For Your June 2022 Watch List

A New Summer Lineup of Premium Craft-Cannabis Products Including, Liquid Wax, BHO Vapes, and Premium Small-Batch Flower Now Available Across Canada A New Summer Lineup of Premium Craft-Cannabis Products Including, Liquid Wax, BHO Vapes, and Premium Small-Batch Flower Now Available Across Canada

Broken Coast Cannabis Launches Full Spectrum ‘woah'

Canadian Pot Stocks For Short Term Trading In June The post Are Canadian Marijuana Stocks A Buy Right Now? 3 With Fresh Lows This Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are Canadian Marijuana Stocks A Buy Right Now? 3 With Fresh Lows This Week

Piper Sandler analyst Michael Lavery on Wednesday cut his price target on Tilray Brands Inc. TLRY, -1.11% to $3 a share from $6 in the face of tough market conditions. While Tilray's direct access to the European market and its positive margins on its earnings before interest, taxes, depreciation and amortization (Ebitda) allow it to stand apart from competitors, the company faces headwinds from further market share loss in the Canadian adult use cannabis market as well as from softer-than-expected U.S. alcohol sales from its Sweetwater brand and an unfavorable currency exchange rate, Lavery said.

Piper Sandler slashes Tilray price target in half

HEXO Corp

Tilray just greatly improved the terms for its previously announced investment in Hexo.

Here's Why Tilray and Canopy Growth Jumped Tuesday but Hexo Crashed

Tilray Brands Inc. TLRY, -7.69% rose 1.3% in premarket trades on Tuesday after the cannabis company said it crafted more favorable terms in its deal to acquire Hexo Corp. HEXO, -6.83% . Tilray reiterated a target of up to C$80 million ($61.9 million) in cost savings for the deal, which it said will add to earnings upon the expected closing date on or around July 15.

Tilray to pay lower price to buy Hexo

Amended Terms Include Increased Discount on Purchase Price of HEXO Note and Reduced Tilray Conversion Price on HEXO Shares

Tilray Brands Announces Enhancements to Accretive Strategic Transaction with HEXO

D.R. Horton

Procter & Gamble

Rolls-Royce Holdings PLC

Snowflake

United Rentals

Due to the market selloff, there are several bargain stocks to buy, giving you a great opportunity to build a solid portfolio. The post 7 Bargain Stocks to Buy After the Brutal Selloff appeared first on InvestorPlace.

7 Bargain Stocks to Buy After the Brutal Selloff

Could Top Canadian Pot Stocks Begin To See Momentum This Summer? The post Best Canadian Cannabis Stocks Right Now? 3 For Your Watchlist In June appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Canadian Cannabis Stocks Right Now? 3 For Your Watchlist In June

Investors might be wary of just how attainable Tilray's 2024 revenue goal is.

Why Tilray Shares Got Smoked This Week

Tilray Inc (NASDAQ: TLRY) slipped to a new 52-week low on Thursday as the stock continued in a consistent 16-month downtrend that began in February 2021. Tilray is also trading in a downtrend on the daily chart, which began on May 17, when the stock topped out at $5.15 following a brief.

Here's Why More Pain Looks Likely For Tilray Bulls

LEAMINGTON, Ontario, June 07, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis brand, Aphria, has launched CBN Night Oil, the brand's first CBN oil medical product formulated for patients' nighttime use.

Tilray Medical Launches Sleep-Oriented CBN Night Oil for Medical Cannabis Patients in Canada

Vinco Ventures

Camber Energy

Skillz

Vroom

Wish

In the case of these seven popular penny stocks, their respective declines are as much the product of worsening fundamentals as they are the product of changing market conditions. The post 7 Popular Penny Stocks to Avoid at All Costs appeared first on InvestorPlace.

7 Popular Penny Stocks to Avoid at All Costs

Green Thumb Industries Inc.

Curaleaf will likely experience even more growth in the years ahead.

This Cannabis Company Is Expecting a "Very Substantial Growth Year" in 2022

Canadian Pot Stocks For June 2022 The post Top Canadian Marijuana Stocks To Watch In June 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks To Watch In June 2022

HEXO stock will have to navigate a thorny path to cash flow positivity. Hence, TLRY is a much better proposition in the cannabis space.

Want to Invest in Pot Stocks? Buy Tilray, Not HEXO

Flora Growth Corp

High Tide

Boston Beer Company

Urban-gro

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.

6 Cannabis Stocks Trying to Burn the Bears This Week

News for Tilray Brands Stock (TLRY)